D Eichenlaub, G Rogler, H G Hoffmann, H J Weise. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAfrica, EasternAntimalarialsBerlinDrug Combinations/therapeutic useFemaleHumansMalaria/prevention & controlMaleMiddle AgedPlasmodium falciparumPyrimethamine/therapeutic useSulfadoxine/therapeutic useSulfanilamides/therapeutic useTravel
Substances: See more » AntimalarialsDrug CombinationsSulfanilamidesfanasil, pyrimethamine drug combinationSulfadoxinePyrimethamine
Year: 1982 PMID: 6127518 DOI: 10.1016/s0140-6736(82)90068-x
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321